Revvity Diagnostics Segment Growth Reported; China Market Challenges Noted (finance.yahoo.com)

• Revvity's diagnostics segment grows despite market challenges.
• China headwinds from regulation and market conditions.
• Analysis highlights competitive dynamics for multiomics sector.

"Revvity, a life sciences company, reported strength in its diagnostics business but faces headwinds in China due to regulatory and market conditions. The analysis highlights competitive dynamics in the diagnostics sector relevant to multiomics service providers."